Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine receptor A1 and A2A subtypes are integral membrane proteins in the G protein-coupled receptor family, activated by extracellular adenosine. A1 receptors are predominantly inhibitory, slowing metabolic activity in the brain and suppressing neurotransmitter release, with a key protective role in neurons and the heart. A2A receptors, in contrast, stimulate adenylate cyclase, increase cAMP, and have prominent anti-inflammatory and neuro-modulatory roles, especially in the brain and immune cells. Both subtypes are highly relevant in diverse diseases—cardiovascular, neurological, and oncological settings—and are targeted by numerous clinically used and investigational drugs.
Agonists bind and activate the receptor, triggering downstream G protein-mediated signaling, altering adenylate cyclase activity (A1 inhibits, A2A stimulates) Antagonists block receptor activation, modulating neurotransmission and cardiovascular function Selective modulation of neurotransmitter release, inflammatory pathways, or cardiac conduction
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine receptor A1; Adenosine receptor A2A (A1AR; A2AAR).